Serious Drug-Related Toxicity in Phase I Clinical Trials

Supporting Publications

Probability of Cycle-One Serious Drug-Related Toxicity in Phase I Clinical Trials

Estimating a patient’s risk for early serious drug-related toxicity (SDRT) at the time of enrollment in phase I trials